U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07358962) titled 'Mild Cognitive Impairment and Psychopathology' on Jan. 14.
Brief Summary: Mild Cognitive Impairment (MCI) is a condition characterized by cognitive deterioration greater than what is expected from normal aging, representing an important risk factor for the development of dementia. Early assessment of cognitive functions is therefore essential for promptly identifying any signs of decline. In addition to cognitive aspects, it is equally important to consider the possible psychopathological profile of patients, as such disorders can significantly influence the progression of the disease, quality of life, and the ability to manage dail...